Abivax
Abivax Stock Surges on Reports of $17.5 Billion Eli Lilly Takeover Interest
Abivax; ABVX; Eli Lilly; takeover bid; stock surge; obefazimod
Abivax aces pair of phase 3 ulcerative colitis trials as end of cash runway looms
Abivax; Obefazimod; ulcerative colitis; Phase 3 trial; clinical remission; ABTECT-1; ABTECT-2; cash runway; induction trials; oral miR-124 enhancer; maintenance trial